Abstract:The epigenetic memory stored in the dynamic modifications, such as base modifications of cytosine (C) in DNA, including methylation/hydroxymethylation/demethylation, causes heritable phenotypes via regulating gene expression without alteration of DNA sequence. The process from cytosine modification to the epigenetic effect is orchestrated by complicated machinery consisting of writers, erasers, readers, and other factors. The two major forms of cytosine modification include methylcytosine (5-mC) and hydroxymethylcytosine (5-hmC). DNA methyltransferases (DNMTs) including DNMT1, DNMT3A, and DNMT3B function as writers for 5-mC. The ten-eleven translocation proteins (TET) including TET1, TET2, and TET3 in the mammalian genome are responsible for hydroxymethylation of 5-mC to generate 5-hmC, 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC). The 5-mC and 5-hmC have become the two most extensively investigated epigenetic markers, and the dynamic balance of these two markers shape the landscape of the epigenome, functioning as a platform to regulate gene expression epigenetically. The landscape of the 5-hmC in epigenome is precisely and tightly regulated during the development. Aberrant alterations of the epigenetic regulation may cause severe consequences such as phenotype change as well as initiation of disease. Progressively, significant achievements have been made in characterization of writers, erasers, and readers of 5-mC and 5-hmC, as well as the contribution of aberrant alteration of 5-hmC/5-mC landscape to the pathogenesis of human diseases, such as cancers and neurological disorders. This article will highlight the research advances in the distinct contribution of TET proteins as suppressors or promoters to the pathogenesis of tumorigenesis and progression. Furthermore, this article also discusses the challenges and the directions for research in the future.

Understanding the role of ten-eleven translocation family proteins in kidney diseases

Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers?

Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine.

Mechanism and Function of Oxidative Reversal of DNA and RNA Methylation

TET (Ten-eleven translocation) family proteins: structure, biological functions and applications

The Molecular Basis Of Dna Demethylation

Role of TET enzymes in DNA methylation, development, and cancer

The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural development

Structure and Function of TET Enzymes

Multiple Functions of Ten-eleven Translocation 1 During Tumorigenesis.

TET Enzymes Regulate Skeletal Development Through Increasing Chromatin Accessibility of RUNX2 Target Genes

Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma

Unraveling the epigenetic code: human kidney DNA methylation and chromatin dynamics in renal disease development

DNA methylation, its mediators and genome integrity.

Tet1 Regulates Dna Replication Through Targeting of Minichromosome Maintenance Genes

5-Hydroxymethylcytosine and Disease.

Genetic Studies Highlight the Role of TET2 and INO80 in DNA Damage Response and Kidney Disease Pathogenesis

Role of DNA De Novo (de)methylation in the Kidney in Salt-Induced Hypertension

The role of TET2 in solid tumors and its therapeutic potential: a comprehensive review

The Emerging Role of Epigenetic Methylation in Kidney Disease

5-hydroxymethylcytosine-mediated DNA demethylation in stem cells and development.